American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
Cancer-associated venous thromboembolism: burden, mechanisms, and management
Venous thromboembolism (VTE) is a significant health problem in the general population
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …
but especially in cancer patients. In this review, we discuss the epidemiology and burden of …
Apixaban to prevent venous thromboembolism in patients with cancer
M Carrier, K Abou-Nassar, R Mallick… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with …
D Farge, H Bounameaux, B Brenner… - The Lancet …, 2016 - thelancet.com
Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at an increased risk of developing VTE and are more likely to …
cancer. These patients are at an increased risk of developing VTE and are more likely to …
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
GH Lyman, AA Khorana, NM Kuderer… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To provide recommendations about prophylaxis and treatment of venous
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis
IL Holster, VE Valkhoff, EJ Kuipers, ETTL Tjwa - Gastroenterology, 2013 - Elsevier
BACKGROUND & AIMS: A new generation of oral anticoagulants (nOAC), which includes
thrombin and factor Xa inhibitors, has been shown to be effective, but little is known about …
thrombin and factor Xa inhibitors, has been shown to be effective, but little is known about …
Cancer-associated thrombosis: an overview
G Elyamany, AM Alzahrani… - Clinical Medicine …, 2014 - journals.sagepub.com
Venous thromboembolism (VTE) is a common complication in patients with malignant
disease. Emerging data have enhanced our understanding of cancer-associated …
disease. Emerging data have enhanced our understanding of cancer-associated …
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH
3 METHODS We performed the pooled analysis using the Review Manager v5. 3 (Nordic
Cochrane Center) according to the recommendations from the Cochrane Collaboration. The …
Cochrane Center) according to the recommendations from the Cochrane Collaboration. The …
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
M Di Nisio, E Porreca, M Candeloro… - Cochrane Database …, 2016 - cochranelibrary.com
Background Venous thromboembolism (VTE) often complicates the clinical course of
cancer. The risk is further increased by chemotherapy, but the trade‐off between safety and …
cancer. The risk is further increased by chemotherapy, but the trade‐off between safety and …
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …
JAC Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - discovery.ucl.ac.uk
BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …